{"id":261288,"date":"2026-09-22T11:22:35","date_gmt":"2026-09-22T05:52:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=261288"},"modified":"2026-10-16T10:27:26","modified_gmt":"2026-10-16T04:57:26","slug":"why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/","title":{"rendered":"SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) PHARMALAB Share Price near 52-week high as stock trades at Rs 1,303"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)<\/a> share price is trading within 2% of its 52-week high today and stood at Rs 1,303, up 3.72% from the previous close. Market cap was Rs 8,042.29 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">SYMBIOTEC Share Price is trading at Rs 1,303, up 3.72% today, and is positioned close to its 52-week high while the company\u2019s market capitalisation stands at Rs 8,042.29 crore. The move keeps SYMBIOTEC Share Price in focus across SYMBIOTEC Share Price Today and SYMBIOTEC Stock News searches because the latest Univest data confirms a one-year high zone event, but does not establish any company-specific catalyst.<\/p>\n<p style=\"margin-top:0!important;\">The latest Univest figures show SYMBIOTEC Share Price moving above the prior session\u2019s level of Rs 1,256.25 after opening at Rs 1,246.05 and touching an intraday high of Rs 1,305.50. For readers tracking SYMBIOTEC Share Price Live, the price action places the stock in the near 52-week high category, which naturally lifts search interest around SYMBIOTEC Share Price Today, SYMBIOTEC Share News and SYMBIOTEC Share Price Update.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#SYMBIOTEC_Share_Price_Today_Price_Action_Analysis\" title=\"SYMBIOTEC Share Price Today: Price Action Analysis\">SYMBIOTEC Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Fundamental_Analysis\" title=\"SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#FAQPage_JSON-LD\" title=\"FAQPage JSON-LD\">FAQPage JSON-LD<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#Why_Investors_Are_Watching_SYMBIOTEC\" title=\"Why Investors Are Watching SYMBIOTEC\">Why Investors Are Watching SYMBIOTEC<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#About_SYMBIOTEC\" title=\"About SYMBIOTEC\">About SYMBIOTEC<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#Why_is_SYMBIOTEC_Share_Price_trending_today\" title=\"Why is SYMBIOTEC Share Price trending today?\">Why is SYMBIOTEC Share Price trending today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#What_is_SYMBIOTEC_Share_Price_today\" title=\"What is SYMBIOTEC Share Price today?\">What is SYMBIOTEC Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#How_close_is_SYMBIOTEC_to_its_52-week_high\" title=\"How close is SYMBIOTEC to its 52-week high?\">How close is SYMBIOTEC to its 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#What_is_SYMBIOTEC_market_capitalisation\" title=\"What is SYMBIOTEC market capitalisation?\">What is SYMBIOTEC market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#What_is_SYMBIOTEC_PE_ratio\" title=\"What is SYMBIOTEC P\/E ratio?\">What is SYMBIOTEC P\/E ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#What_is_SYMBIOTEC_PB_ratio\" title=\"What is SYMBIOTEC P\/B ratio?\">What is SYMBIOTEC P\/B ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#What_do_SYMBIOTEC_ROE_and_ROCE_show\" title=\"What do SYMBIOTEC ROE and ROCE show?\">What do SYMBIOTEC ROE and ROCE show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#What_is_the_latest_SYMBIOTEC_revenue_figure\" title=\"What is the latest SYMBIOTEC revenue figure?\">What is the latest SYMBIOTEC revenue figure?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-price-near-52-week-high-today-2026\/#Track_SYMBIOTEC_Share_Price_on_Univest\" title=\"Track SYMBIOTEC Share Price on Univest\">Track SYMBIOTEC Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"SYMBIOTEC_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>SYMBIOTEC Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At this stage, the verified data supports a simple reading: the stock is trading near its yearly high, the move is visible in the price print, and the company\u2019s valuation metrics remain important to watch. Univest data also points to a stock that is being discussed in the context of SYMBIOTEC Fundamental Analysis, SYMBIOTEC Stock Analysis and broader SYMBIOTEC Latest News coverage.<\/p>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,303<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,256.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 46.75 (+3.72%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,246.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,305.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,235<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 8,042.29 crore<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) traded at Rs 1,303 versus the previous close of Rs 1,256.25, a rise of 3.72%. The stock opened at Rs 1,246.05, reached a high of Rs 1,305.5 and touched a low of Rs 1,235.<\/p>\n<p>SYMBIOTEC Share Price Today shows a move from Rs 1,256.25 to Rs 1,303, a change of Rs 46.75 or 3.72%. The stock opened at Rs 1,246.05, traded between Rs 1,235 and Rs 1,305.50, and is therefore sitting very close to its 52-week high. The intraday range matters here because it shows where the stock is trading within the current market session, while the one-year high context explains why SYMBIOTEC Share Price is drawing attention in SYMBIOTEC Stock News.<\/p>\n<p>Because the stock is near its 52-week peak, readers often search for SYMBIOTEC Share Price Today, SYMBIOTEC Share Price Live and SYMBIOTEC News Today together. The verified numbers confirm the price event, but they do not establish a company-specific reason behind it. That makes the current move a factual market update rather than a stated catalyst story.<\/p>\n<p>For market watchers, the practical question is not whether SYMBIOTEC Share Price moved, but how the move fits into the broader context of its one-year high zone. Univest continues to track the stock\u2019s price action and related market updates for readers following SYMBIOTEC Share Price Update and SYMBIOTEC Share News.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Fundamental_Analysis\"><\/span><strong>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 8,042.29 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">73.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.38x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 233.38<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) fundamental metrics show P\/E 73.45x, P\/B 5.38x, ROE 11.22%, ROCE 12.41%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD has a market capitalisation of Rs 8,042.29 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 73.45x, P\/B at 5.38x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.22% and ROCE of 12.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.1, book value per share of Rs 233.38, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 27.24x, median ROE of 11.48%, median ROCE of 13.28%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">73.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.24x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 640x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.38x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.81x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.48%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 8,042.29 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 795.25 crore<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P\/E ratio of 73.45x, which is above the benchmark median of 27.24x, a difference of +169.64%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROE of 11.22%, which is below the benchmark median of 11.48%, a difference of -2.26%. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROCE of 12.41%, which is below the benchmark median of 13.28%, a difference of -6.55%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FAQPage_JSON-LD\"><\/span><strong>FAQPage JSON-LD<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>{&#8220;@context&#8221;:&#8221;https:\/\/schema.org&#8221;,&#8221;@type&#8221;:&#8221;FAQPage&#8221;,&#8221;mainEntity&#8221;:[{&#8220;@type&#8221;:&#8221;Question&#8221;,&#8221;name&#8221;:&#8221;Why is SYMBIOTEC Share Price trending today?&#8221;,&#8221;acceptedAnswer&#8221;:{&#8220;@type&#8221;:&#8221;Answer&#8221;,&#8221;text&#8221;:&#8221;SYMBIOTEC Share Price is trending because it is trading near its 52-week high at Rs 1,303, up 3.72% from the previous session. The market-cap reading of Rs 8,042.29 crore also keeps it in view.&#8221;}},{&#8220;@type&#8221;:&#8221;Question&#8221;,&#8221;name&#8221;:&#8221;What is SYMBIOTEC Share Price today?&#8221;,&#8221;acceptedAnswer&#8221;:{&#8220;@type&#8221;:&#8221;Answer&#8221;,&#8221;text&#8221;:&#8221;SYMBIOTEC Share Price today is Rs 1,303. It moved up from the previous close of Rs 1,256.25 and traded between Rs 1,235 and Rs 1,305.50 during the session.&#8221;}},{&#8220;@type&#8221;:&#8221;Question&#8221;,&#8221;name&#8221;:&#8221;How close is SYMBIOTEC to its 52-week high?&#8221;,&#8221;acceptedAnswer&#8221;:{&#8220;@type&#8221;:&#8221;Answer&#8221;,&#8221;text&#8221;:&#8221;SYMBIOTEC Share Price is very close to its 52-week high after touching Rs 1,305.50. That keeps SYMBIOTEC Stock News focused on the yearly high zone rather than a broad range move.&#8221;}},{&#8220;@type&#8221;:&#8221;Question&#8221;,&#8221;name&#8221;:&#8221;What is SYMBIOTEC market capitalisation?&#8221;,&#8221;acceptedAnswer&#8221;:{&#8220;@type&#8221;:&#8221;Answer&#8221;,&#8221;text&#8221;:&#8221;SYMBIOTEC market capitalisation is Rs 8,042.29 crore. This figure helps frame SYMBIOTEC Share Price against other listed healthcare and pharmaceuticals companies in the same industry benchmark.&#8221;}},{&#8220;@type&#8221;:&#8221;Question&#8221;,&#8221;name&#8221;:&#8221;What is SYMBIOTEC P\/E ratio?&#8221;,&#8221;acceptedAnswer&#8221;:{&#8220;@type&#8221;:&#8221;Answer&#8221;,&#8221;text&#8221;:&#8221;SYMBIOTEC Share Price corresponds to a P\/E ratio of 73.45. That is above the same-industry median of 27.24 and the average of 39.45 in the benchmark set.&#8221;}},{&#8220;@type&#8221;:&#8221;Question&#8221;,&#8221;name&#8221;:&#8221;What is SYMBIOTEC P\/B ratio?&#8221;,&#8221;acceptedAnswer&#8221;:{&#8220;@type&#8221;:&#8221;Answer&#8221;,&#8221;text&#8221;:&#8221;SYMBIOTEC Share Price has a P\/B ratio of 5.38. The same-industry median is 2.81 and the average is 4.16, so the stock trades above the benchmark on book value multiples.&#8221;}},{&#8220;@type&#8221;:&#8221;Question&#8221;,&#8221;name&#8221;:&#8221;What do SYMBIOTEC ROE and ROCE show?&#8221;,&#8221;acceptedAnswer&#8221;:{&#8220;@type&#8221;:&#8221;Answer&#8221;,&#8221;text&#8221;:&#8221;SYMBIOTEC Share Price is backed by ROE of 11.22% and ROCE of 12.41%. Both are close to the industry median, which provides useful context for SYMBIOTEC Fundamental Analysis.&#8221;}},{&#8220;@type&#8221;:&#8221;Question&#8221;,&#8221;name&#8221;:&#8221;What is the latest SYMBIOTEC revenue figure?&#8221;,&#8221;acceptedAnswer&#8221;:{&#8220;@type&#8221;:&#8221;Answer&#8221;,&#8221;text&#8221;:&#8221;The latest quarterly revenue shown for SYMBIOTEC is Rs 218.15 crore for Jun 2026. This helps readers compare SYMBIOTEC Share Price with the company\u2019s reported business scale.&#8221;}}]}<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/suven\/suven-life-sciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Suven Life Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUVEN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8,014.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-101.8<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-78.71<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aartipharm\/aarti-pharmalabs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aarti Pharmalabs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AARTIPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,856.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.72<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sanoficonr\/sanofi-consumer-healthcare-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sanofi Consumer Healthcare India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SANOFICONR<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8,267.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">73.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">98.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/pghl\/procter-and-gamble-health-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Procter &amp; Gamble Health Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PGHL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8,567.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.86<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/blissgvs\/bliss-gvs-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Bliss GVS Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BLISSGVS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,029.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">51.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.4<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P\/E ratio of 73.45x compared with the displayed peer median of 31.08x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.22% compares with a peer median of 12.11% across the companies shown in the table. ROCE stood at 12.41% versus the displayed peer median of 17.4%, providing a capital-efficiency comparison. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a market capitalisation of Rs 8,042.29 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_SYMBIOTEC\"><\/span><strong>Why Investors Are Watching SYMBIOTEC<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>SYMBIOTEC Share Price is trading at Rs 1,303, up 3.72% from the previous session\u2019s Rs 1,256.25.<\/li>\n<li>The stock is near its 52-week high after touching Rs 1,305.50 during the session.<\/li>\n<li>Market capitalisation stands at Rs 8,042.29 crore, which helps frame SYMBIOTEC Market Cap searches.<\/li>\n<li>P\/E is 73.45 and P\/B is 5.38, both above the same-industry median.<\/li>\n<li>ROE is 11.22% and ROCE is 12.41%, which give additional SYMBIOTEC Fundamental Analysis context.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_SYMBIOTEC\"><\/span><strong>About SYMBIOTEC<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>SYMBIOTEC PHARMALAB LTD operates in the Healthcare sector and the Pharmaceuticals &#038; Drugs industry. For readers following SYMBIOTEC Company News, this classification is the core business context available in the market record used by Univest. The company\u2019s listed identity, sector and industry are the main descriptive anchors for SYMBIOTEC Share Price, SYMBIOTEC NSE and SYMBIOTEC BSE searches.<\/p>\n<p>The current market view is therefore driven by the share price event, valuation multiples and peer context rather than by a longer business description. That makes SYMBIOTEC Share Price, SYMBIOTEC Stock Performance and SYMBIOTEC Latest News the most useful entry points for ongoing tracking on Univest.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_SYMBIOTEC_Share_Price_trending_today\"><\/span><strong>Why is SYMBIOTEC Share Price trending today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SYMBIOTEC Share Price is trending because it is trading near its 52-week high at Rs 1,303, up 3.72% from the previous session. The market-cap reading of Rs 8,042.29 crore also keeps it in view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_SYMBIOTEC_Share_Price_today\"><\/span><strong>What is SYMBIOTEC Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SYMBIOTEC Share Price today is Rs 1,303. It moved up from the previous close of Rs 1,256.25 and traded between Rs 1,235 and Rs 1,305.50 during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_close_is_SYMBIOTEC_to_its_52-week_high\"><\/span><strong>How close is SYMBIOTEC to its 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SYMBIOTEC Share Price is very close to its 52-week high after touching Rs 1,305.50. That keeps SYMBIOTEC Stock News focused on the yearly high zone rather than a broad range move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_SYMBIOTEC_market_capitalisation\"><\/span><strong>What is SYMBIOTEC market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SYMBIOTEC market capitalisation is Rs 8,042.29 crore. This figure helps frame SYMBIOTEC Share Price against other listed healthcare and pharmaceuticals companies in the same industry benchmark. The company operates in the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_SYMBIOTEC_PE_ratio\"><\/span><strong>What is SYMBIOTEC P\/E ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SYMBIOTEC Share Price corresponds to a P\/E ratio of 73.45. That is above the same-industry median of 27.24 and the average of 39.45 in the benchmark set. Its P\/B ratio is 5.38x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_SYMBIOTEC_PB_ratio\"><\/span><strong>What is SYMBIOTEC P\/B ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SYMBIOTEC Share Price has a P\/B ratio of 5.38. The same-industry median is 2.81 and the average is 4.16, so the stock trades above the benchmark on book value multiples.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_SYMBIOTEC_ROE_and_ROCE_show\"><\/span><strong>What do SYMBIOTEC ROE and ROCE show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SYMBIOTEC Share Price is backed by ROE of 11.22% and ROCE of 12.41%. Both are close to the industry median, which provides useful context for SYMBIOTEC Fundamental Analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_SYMBIOTEC_revenue_figure\"><\/span><strong>What is the latest SYMBIOTEC revenue figure?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest quarterly revenue shown for SYMBIOTEC is Rs 218.15 crore for Jun 2026. This helps readers compare SYMBIOTEC Share Price with the company\u2019s reported business scale.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is SYMBIOTEC Share Price trending today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SYMBIOTEC Share Price is trending because it is trading near its 52-week high at Rs 1,303, up 3.72% from the previous session. The market-cap reading of Rs 8,042.29 crore also keeps it in view.\"}},{\"@type\":\"Question\",\"name\":\"What is SYMBIOTEC Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SYMBIOTEC Share Price today is Rs 1,303. It moved up from the previous close of Rs 1,256.25 and traded between Rs 1,235 and Rs 1,305.50 during the session.\"}},{\"@type\":\"Question\",\"name\":\"How close is SYMBIOTEC to its 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SYMBIOTEC Share Price is very close to its 52-week high after touching Rs 1,305.50. That keeps SYMBIOTEC Stock News focused on the yearly high zone rather than a broad range move.\"}},{\"@type\":\"Question\",\"name\":\"What is SYMBIOTEC market capitalisation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SYMBIOTEC market capitalisation is Rs 8,042.29 crore. This figure helps frame SYMBIOTEC Share Price against other listed healthcare and pharmaceuticals companies in the same industry benchmark. The company operates in the Healthcare sector.\"}},{\"@type\":\"Question\",\"name\":\"What is SYMBIOTEC P\/E ratio?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SYMBIOTEC Share Price corresponds to a P\/E ratio of 73.45. That is above the same-industry median of 27.24 and the average of 39.45 in the benchmark set. Its P\/B ratio is 5.38x.\"}},{\"@type\":\"Question\",\"name\":\"What is SYMBIOTEC P\/B ratio?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SYMBIOTEC Share Price has a P\/B ratio of 5.38. The same-industry median is 2.81 and the average is 4.16, so the stock trades above the benchmark on book value multiples.\"}},{\"@type\":\"Question\",\"name\":\"What do SYMBIOTEC ROE and ROCE show?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SYMBIOTEC Share Price is backed by ROE of 11.22% and ROCE of 12.41%. Both are close to the industry median, which provides useful context for SYMBIOTEC Fundamental Analysis.\"}},{\"@type\":\"Question\",\"name\":\"What is the latest SYMBIOTEC revenue figure?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest quarterly revenue shown for SYMBIOTEC is Rs 218.15 crore for Jun 2026. This helps readers compare SYMBIOTEC Share Price with the company\u2019s reported business scale.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_SYMBIOTEC_Share_Price_on_Univest\"><\/span><strong>Track SYMBIOTEC Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Readers can track SYMBIOTEC Share Price Live on Univest along with SYMBIOTEC Share Price Today, market cap, valuation ratios, sector comparison and the latest one-year high zone updates. Univest also helps users follow SYMBIOTEC Stock News, SYMBIOTEC Fundamental Analysis and SYMBIOTEC Share Price Update in one place.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SYMBIOTEC PHARMALAB LTD Share Price trades near its 52-week high at Rs 1,303, marking a 3.72% rise today. Market cap stands at Rs 8,042.29 crore.<\/p>\n","protected":false},"author":38,"featured_media":312749,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-261288","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["312749"],"rank_math_title":["SYMBIOTEC Share Price near 52-week high; valuation check"],"rank_math_description":["SYMBIOTEC Share Price trades near its 52-week high at Rs 1,303, up 3.72%. See price action, valuation, sector and peer context."],"rank_math_focus_keyword":["SYMBIOTEC Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/symbiotec-pharmalab-ltd-symbiotec-pharmalab-share-price-near-52-week-high-as.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=261288"}],"version-history":[{"count":4,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261288\/revisions"}],"predecessor-version":[{"id":312753,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/261288\/revisions\/312753"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/312749"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=261288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=261288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=261288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}